ReviewQuantitative biology (Beijing, China)2026
A comprehensive review of cluster methods for drug-drug interaction network.
Review in Quantitative biology (Beijing, China), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Teaching artificial intelligence through drug-drug interaction clustering analysis: Integrating project-based learning and large language models.PLoS computational biology · 2026Article
- A comprehensive review of cluster methods for drug-drug interaction network.Quantitative biology (Beijing, China) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The detection of drug-drug interaction (DDI) is crucial to the rational use of drug combinations. Experimentally, DDI detection is time-consuming and laborious. Currently, researchers have developed a variety of computational methods to predict DDI. Although there are many reviews that summarized these computational methods, these reviews focused on supervised learning. In this review, we provide a comprehensive and systematic summary of unsupervised (i.e., clustering) methods for DDI network analysis. Unlike previous studies, we highlight the unique advantages of clustering methods DDI prediction and uncovering mechanisms of action. We first introduced common drug information and discussed how to calculate drug similarity using this drug information. Then, we introduced representative clustering algorithms (i.e., drug information-based and network-based methods) and described clustering evaluation metrics. Finally, we discussed the limitations and challenges in this field, and proposed potential research directions. This review aims to promote further exploration and application of clustering methods in drug combination discovery and DDI network analysis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.